|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | N-(3-(Aminomethyl)benzyl)acetamidine | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|||
| 化学式 | C10H15N3.2HCl |
||||||
| 分子量 | 250.17 | CAS No. | 214358-33-5 | ||||
| Solubility (25°C)* | 体外 | DMSO | 35 mg/mL (139.9 mM) | ||||
| Water | 35 mg/mL (139.9 mM) | ||||||
| Ethanol | 35 mg/mL (139.9 mM) | ||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||
| 製品説明 | 1400W (N-(3-(Aminomethyl)benzyl)acetamidine) is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase(iNOS). |
|---|---|
| in vitro | 1400W is either an irreversible inhibitor or an extremely slowly reversible inhibitor of human iNOS. Inhibition of human iNOS by 1400W is time-dependent. 1400W is competitive with L-arginine. 1400W is not a substrate for iNOS[1]. |
| in vivo | 1400W selectively prevents microvasculature injury in rats. 1400W is greater than 50-fold more potent against iNOS than eNOS in a rat model of endotoxin-induced vascular injury. Moreover, 1400W also dose-dependently reduces LPS-induced vascular leakage associated with iNOS induction in the colon, lung, liver, kidney, and heart. The maximal protection is close to 100% for all organs except the kidney (kidney:54%)[1]. 1400W has an ameliorative effect on both oxidative and nitrosative stress in the kidneys against renal I/R injury in rats[2]. Treatment with 1400W can reduce the rate of growth of solid tumors in mice[4]. |
| 細胞アッセイ | 細胞株 | RAW264.7 cells |
|---|---|---|
| 濃度 | 100 μM | |
| 反応時間 | 16 h | |
| 実験の流れ | RAW264.7 cells are treated with LPS/IFNγ for 16 h and GAPDH-p300 binding is abolished by the iNOS inhibitor 1400W (100 μM). Cell lysates are immunoprecipitated with an anti-p300 antibody and the immunoprecipitates are analysed by western blotting with an anti-GAPDH antibody. | |
| 動物実験 | 動物モデル | Rats |
| 投薬量 | 0.1-10 mg/kg | |
| 投与方法 | s.c. |
|
| GRA12 is a common virulence factor across Toxoplasma gondii strains and mouse subspecies [ Nat Commun, 2025, 16(1):3570] | PubMed: 40240328 |
| iNOS-Produced Nitric Oxide from Cancer Cells as an Intermediate of Stemness Regulation by PARP-1 in Colorectal Cancer [ Biomolecules, 2025, 15(1)125] | PubMed: 39858519 |
| iNOS is necessary for GBP-mediated T. gondii clearance in murine macrophages via vacuole nitration and intravacuolar network collapse [ Nat Commun, 2024, 15(1):2698] | PubMed: 38538595 |
| Uncovering therapeutic targets for macrophage-mediated T cell suppression and PD-L1 therapy sensitization [ Cell Rep Med, 2024, S2666-3791(24)00419-1] | PubMed: 39181134 |
| Normalization of CF Immune System Reverses Intestinal Neutrophilic Inflammation and Significantly Improves the Survival of CF Mice [ Cell Mol Gastroenterol Hepatol, 2024, S2352-345X(24)00179-6] | PubMed: 39510500 |
| Nitric oxide facilitates the S-nitrosylation and deubiquitination of Notch1 protein to maintain cancer stem cells in human NSCLC [ J Cell Mol Med, 2024, 28(21):e70203] | PubMed: 39523215 |
| Ninjinyoeito Prevents Onset of Depression-Like Behavior and Reduces Hippocampal iNOS Expression in Senescence-Accelerated Mouse Prone 8 Mice [ Evid Based Complement Alternat Med, 2023, 2023:2151004] | PubMed: 37593014 |
| Ninjinyoeito Prevents Onset of Depression-Like Behavior and Reduces Hippocampal iNOS Expression in Senescence-Accelerated Mouse Prone 8 Mice [ Evid Based Complement Alternat Med, 2023, 2023:2151004] | PubMed: 37593014 |
| Inducible nitric oxide synthase (iNOS) is necessary for GBP-mediated T. gondii restriction in murine macrophages via vacuole nitration and intravacuolar network collapse [ bioRxiv, 2023, 2023.07.24.549965] | PubMed: 37546987 |
| Inducible nitric oxide synthase (iNOS) is necessary for GBP-mediated T. gondii restriction in murine macrophages via vacuole nitration and intravacuolar network collapse [ bioRxiv, 2023, 2023.07.24.549965] | PubMed: 37546987 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。